ES2028493A6 - Un metodo para preparar una composicion destinada a inhibir la proliferacion virica: - Google Patents

Un metodo para preparar una composicion destinada a inhibir la proliferacion virica:

Info

Publication number
ES2028493A6
ES2028493A6 ES8803032A ES8803032A ES2028493A6 ES 2028493 A6 ES2028493 A6 ES 2028493A6 ES 8803032 A ES8803032 A ES 8803032A ES 8803032 A ES8803032 A ES 8803032A ES 2028493 A6 ES2028493 A6 ES 2028493A6
Authority
ES
Spain
Prior art keywords
phosphatidyl
treatment
viral disease
phosphatides
virus
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
ES8803032A
Other languages
English (en)
Inventor
Marti Jett-Tilton
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Houston Biotechnology Inc
Original Assignee
Houston Biotechnology Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Houston Biotechnology Inc filed Critical Houston Biotechnology Inc
Publication of ES2028493A6 publication Critical patent/ES2028493A6/es
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/829—Liposomes, e.g. encapsulation

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Dispersion Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)

Abstract

METODO PARA PREPARAR UNA COMPOSICION DESTINDA A INHIBIR LA PROLIFERACION VIRICA. CONSISTE EN MEZCLAR AL MENOS UN DIACILFOSFATIDO, EN QUE EL GRUPO ACILO EN LA POSICION SNSI2 ESTA POLIINSATURADO, CON UN MEDIO ACEPTABLE QUE TIENE UN PH DE APROXIMADAMENTE 6 A 8,5, OSCILANDO LA CONCENTRACION DE DICHO DIACILFOSFATIDO ENTRE 1MG/ML Y 100MG/ML APROXIMADAMENTE. EL INVENTO ES UTIL PARA TRATAR INFLUENZA, HERPES, PAPILOMAS Y OTRAS ENFERMEDADES VIRICAS.
ES8803032A 1987-10-06 1988-10-06 Un metodo para preparar una composicion destinada a inhibir la proliferacion virica: Expired - Fee Related ES2028493A6 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/106,615 US4997761A (en) 1987-10-06 1987-10-06 Phosphatidyl treatment of viral disease

Publications (1)

Publication Number Publication Date
ES2028493A6 true ES2028493A6 (es) 1992-07-01

Family

ID=22312366

Family Applications (1)

Application Number Title Priority Date Filing Date
ES8803032A Expired - Fee Related ES2028493A6 (es) 1987-10-06 1988-10-06 Un metodo para preparar una composicion destinada a inhibir la proliferacion virica:

Country Status (9)

Country Link
US (1) US4997761A (es)
EP (1) EP0338058A4 (es)
JP (1) JPH02501743A (es)
DK (1) DK272289D0 (es)
ES (1) ES2028493A6 (es)
FI (1) FI892470A (es)
GR (1) GR880100666A (es)
PT (1) PT88684A (es)
WO (1) WO1989003220A1 (es)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1990015609A1 (en) * 1989-06-15 1990-12-27 Med-Tal, Inc. Prevention and treatment of microbial infection by phosphoglycerides
DE3934820A1 (de) * 1989-10-19 1991-04-25 Boehringer Mannheim Gmbh Verwendung von lecithin-analoga als antivirale arzneimittel und neue derivate
FR2658418B1 (fr) * 1990-02-20 1994-09-02 Synthelabo Compositions pharmaceutiques a base de phospholipides.
US5188951A (en) * 1990-04-17 1993-02-23 The Liposome Company, Inc. Enzymatic synthesis of soluble phosphatides from phospholipids
ES2132780T3 (es) * 1990-04-17 1999-08-16 Liposome Co Inc Sintesis enzimatica de fosfatidos solubles a partir de fosfolipidos.
SE502989C2 (sv) * 1993-11-22 1996-03-04 Perstorp Ab Användning av en inositoltrisfosfatester för beredning av läkemedel
SE502574C2 (sv) * 1994-01-25 1995-11-13 Perstorp Ab En farmaceutisk komposition med förbättrad biotillgänglighet hos inositolfosfat
US7135584B2 (en) * 1995-08-07 2006-11-14 Wake Forest University Lipid analogs for treating viral infections
WO1996006620A2 (en) * 1994-08-29 1996-03-07 Wake Forest University Lipid analogs for treating viral infections
JPH10506396A (ja) * 1994-10-03 1998-06-23 ジェ． ベルジュロン，ミシェル Ａｉｄｓ及びいくつかの他のウィルス性疾患を治療するための方法及び製剤
US7026469B2 (en) * 2000-10-19 2006-04-11 Wake Forest University School Of Medicine Compositions and methods of double-targeting virus infections and cancer cells
US7309696B2 (en) 2000-10-19 2007-12-18 Wake Forest University Compositions and methods for targeting cancer cells
ATE308548T1 (de) * 2000-11-07 2005-11-15 I R B Istituto Di Ricerche Bio Glycerophosphoinositol-derivate als cytosolic a2 phospholipase modulatoren
JP2004520175A (ja) * 2001-05-29 2004-07-08 コーニンクレッカ　フィリップス　エレクトロニクス　エヌ　ヴィ 金属−セラミック接合
US7551837B2 (en) * 2001-08-31 2009-06-23 Thomson Licensing Sequence counter for an audio visual stream
US7585523B2 (en) * 2002-08-27 2009-09-08 Targeted Medical Pharma Composition and method to augment and sustain neurotransmitter production
WO2005027933A1 (en) * 2003-09-23 2005-03-31 The Corporation Of The Trustees Of The Order Of The Sisters Of Mercy In Queensland Unsaturated phosphatidylcholines and uses thereof
US20050187191A1 (en) * 2004-02-20 2005-08-25 Kucera Louis S. Methods and compositions for the treatment of respiratory syncytial virus
US7825270B2 (en) * 2005-12-21 2010-11-02 Nutrimed Biotech Inositolphospholipids and analogues: phosphatidylinositol products and processes
CA2654631A1 (en) * 2006-06-09 2007-12-13 Erasmus University Medical Center Rotterdam Modulation of the immune system by inositol phospholipids
JP5670858B2 (ja) * 2011-10-14 2015-02-18 イ．エルレ．ビ．イスティトゥト ディ リチェルケ ビオテクノロジケ ソチエタ ペル アツィオニ サイトゾルのホスホリパーゼのモジュレーターとしてのグリセロホスホイノシトール誘導体
KR20210013085A (ko) * 2018-05-15 2021-02-03 플래그쉽 파이어니어링 이노베이션스 브이아이, 엘엘씨 병원체 방제 조성물 및 그의 용도

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5782311A (en) * 1980-11-11 1982-05-22 Tanabe Seiyaku Co Ltd Production of liposome preparation
US4513008A (en) * 1982-07-30 1985-04-23 The Vinoxen Company, Inc. Virucidal compositions and therapy
US4666893A (en) * 1983-02-15 1987-05-19 St. Thomas Institute Methods of inducing resistance to bacterial and viral infections
JPS6124519A (ja) * 1984-07-11 1986-02-03 Takeda Chem Ind Ltd 抗腫瘍剤
US4857514A (en) * 1985-09-17 1989-08-15 Yeda Research And Development Company, Ltd. Virus inactivation

Also Published As

Publication number Publication date
FI892470A0 (fi) 1989-05-22
EP0338058A4 (en) 1991-07-03
DK272289A (da) 1989-06-02
FI892470A (fi) 1989-05-22
JPH02501743A (ja) 1990-06-14
DK272289D0 (da) 1989-06-02
EP0338058A1 (en) 1989-10-25
GR880100666A (el) 1994-03-31
US4997761A (en) 1991-03-05
PT88684A (pt) 1989-07-31
WO1989003220A1 (en) 1989-04-20

Similar Documents

Publication Publication Date Title
ES2028493A6 (es) Un metodo para preparar una composicion destinada a inhibir la proliferacion virica:
ZA878877B (en) Treatment of diseases caused by viruses
GB2034323B (en) Production of dna comprising the b hepatitis viral genome
DE10399025I1 (de) Wirkstoffvorl{ufer von Phosphonaten
NZ213155A (en) Molecular clones of the genome of hiv (htlv-iii)
DE3773892D1 (de) Medizinische verwendung von nukleosiden.
ES468363A1 (es) Proceso para la fabricacion de un preparado destinado al tra-tamiento de herpes-zoster.
EP0329609A3 (en) Antiviral combination
AU2476388A (en) Therapeutic necleosides
NO168041C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive retinsyreestere av erytromycin.
AU1308188A (en) Methods of treating acquired immune deficiency syndrome (AIDS) caused by human immunodeficiency virus (HIV)
NO880935D0 (no) Fremgangmsaate for paavisning av hiv eller annet virus med lignende klinisk virkning.
EP0340778A3 (en) Prodrugs of 2',3'- didehydro-2',3'-dideoxynucleosides
GB2192003B (en) Enzymatic treatment of thick gluten as an aid to filtration.
NO162618C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive 6-substituerte mitomycinanaloger.
IE55973B1 (en) The use of undecylenic acid for the manufacture of a composition for the treatment of herpes labialis
IT7819604A0 (it) (fosfonici) sostiuiti, procedimento esteri oppure esteri amidi per la loro preparazione e loro pirimidinil(tio)-fosforici impiego come insetticidi, acaricidi e nematocidi.
USD254792S (en) Electric guitar
SU706347A1 (ru) Эмаль
NZ507942A (en) Viral chimeras comprised of CAEV and HIV-1 genetic elements
FR2437415A1 (fr) Nouveaux 5-monophosphates des 5-alkyl(inferieur)-2'-desoxy-uridines, leur procede de preparation et leur utilisation contre les virus de l'herpes
SU713835A1 (ru) Глазурь
AU4030378A (en) Treatment of phosphoric acid
SU704498A1 (ru) Рабочий орган маркера
JPS5435280A (en) Preparation of yeast cells

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 20010201